Salta alla navigazione principale Salta alla ricerca Salta al contenuto principale

Blue rubber bleb nevus syndrome: A European multicenter cohort study

  • Aymeric Becq*
  • , Annouk Bisdorff
  • , Maria Elena Riccioni
  • , Sophie Blaise
  • , Stéphanie Mallet
  • , Ervin Toth
  • , Annabel Maruani
  • , Edward Despott
  • , Christine Labreze
  • , Pablo Cortegoso Valdivia
  • , Emmanuele Rondonotti
  • , Cristina Carrretero Ribón
  • , Laetitia Goffinet
  • , Elise Coffin
  • , Bruno Rosa
  • , Cynthia Medlij
  • , Jean-Christophe Saurin
  • , Xavier Dray
  • *Autore corrispondente per questo lavoro
  • Université Paris-Est Créteil
  • Université Paris Cité
  • Lund University
  • Université de Tours
  • CHU de Tours
  • The Royal Free Hospital
  • Groupe hospitalier Pellegrin
  • Azienda Ospedaliero - Universitaria di Parma
  • Ospedale Valduce
  • University of Navarra
  • CHU de Nancy
  • Hôpital Foch
  • Hospital da Senhora da Oliveira
  • Hôpital Saint-Joseph
  • Sorbonne Université

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

Background and aim: Blue Rubber Bleb Nevus Syndrome (BRBNS) is a rare congenital vascular entity, mainly characterized by cutaneous and gastrointestinal venous malformations. BRBNS remains relatively unexplored and only limited descriptive data is available. The aim of this study was to evaluate the clinical features, diagnostic work-up and therapeutic management in current practice. Methods: A multicenter, European, cohort study was performed to investigate the BRBNS population. Patient demographics, clinical presentation and management data were collected. Results: In this multicenter cohort study including 44 patients, BRBNS is diagnosed at a median age of 12 years, mainly based on clinical presentation (65.9 %). The majority of patients present cutaneous (68.2 %) and digestive (79.5 %) lesions, mainly in the colon and small bowel. D-dimer and fibrinogen levels are checked in <50 % of patients at diagnosis. Tie2/TEK mutation testing is rarely performed. Gastrointestinal bleeding is the most common complication (54.3 %), requiring endoscopic treatment (36.4 %) by various techniques. Conclusions: This is the largest cohort study on BRBNS. Diagnosis is mainly based on clinical presentation. D-dimer, fibrinogen and Tie2/TEK mutation testing should be performed in case of suspected BRBNS as it could help confirm the diagnosis.
Lingua originaleInglese
pagine (da-a)603-608
Numero di pagine6
RivistaDigestive and Liver Disease
Volume57
Numero di pubblicazione2
DOI
Stato di pubblicazionePubblicato - 2025

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

  1. SDG 3 - Salute e benessere
    SDG 3 Salute e benessere

All Science Journal Classification (ASJC) codes

  • Epatologia
  • Gastroenterologia

Keywords

  • Blue rubber bleb nevus syndrome
  • Gastrointestinal bleeding
  • Gastrointestinal endoscopy
  • Sirolimus
  • Vascular malformations

Fingerprint

Entra nei temi di ricerca di 'Blue rubber bleb nevus syndrome: A European multicenter cohort study'. Insieme formano una fingerprint unica.

Cita questo